Efficacy of Remodulin in Adults With Congenital Heart Disease (ACHD) and Pulmonary Hypertension

NCT01980979 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped slow enrollment

Conditions

Congenital Heart Disease

Interventions

DRUG: Remodulin

Sponsor

University of California, Los Angeles

Collaborators

[object Object]